National Committee for Quality Assurance
- All-cause readmissions: the number of acute inpatient stays during the measurement year that were followed by an acute readmission for any diagnosis within 30 days and the predicted probability of an acute readmission, for patients 18 years of age and older. This updates a previously published measure summary.
- Annual monitoring for patients on persistent medications: percentage of patients 18 years of age and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and had at least one therapeutic monitoring event for the therapeutic agent in the measurement year. This updates a previously published measure summary.
- Antidepressant medication management (effective acute phase treatment): percentage of patients 18 years of age and older who were diagnosed with a new episode of major depression, treated with antidepressant medication, and who remained on an antidepressant medication for at least 84 days (12 weeks). This updates a previously published measure summary.
- Antidepressant medication management (effective continuation phase treatment): percentage of patients 18 years of age and older who were diagnosed with a new episode of major depression, treated with antidepressant medication, and who remained on an antidepressant medication for at least 180 days (6 months). This updates a previously published measure summary.
- Engagement of alcohol and other drug (AOD) treatment: percentage of patients who initiated treatment and who had two or more additional services with a diagnosis of AOD within 30 days of the initiation visit. This updates a previously published measure summary.
- Follow-up after hospitalization for mental illness: percentage of discharges for patients 6 years of age and older who were hospitalized for treatment of selected mental health disorders and who had an outpatient visit, an intensive outpatient service, or partial hospitalization with a mental health provider within 30 days of discharge.This updates a previously published measure summary.
- Follow-up after hospitalization for mental illness: percentage of discharges for patients 6 years of age and older who were hospitalized for treatment of selected mental health disorders and who had an outpatient visit, an intensive outpatient service, or partial hospitalization with a mental health provider within 7 days of discharge.This updates a previously published measure summary.
- Follow-up care for children prescribed ADHD medication (continuation and maintenance [C&M] phase): percentage of patients 6 to 12 years of age as of the index prescription start date with an outpatient ADHD medication who remained on the medication for at least 210 days and who, in addition to the visit in the initiation phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the initiation phase ended. This updates a previously published measure summary.
- Follow-up care for children prescribed ADHD medication (initiation phase): percentage of patients 6 to 12 years of age as of the index prescription start date with an outpatient ADHD medication who had one follow-up visit with a practitioner with prescribing authority during the 30-day initiation phase. This updates a previously published measure summary.
- Initiation of alcohol and other drug (AOD) treatment: percentage of patients who initiate treatment through an inpatient AOD admission, outpatient visit, intensive outpatient service or partial hospitalization within 14 days of the diagnosis. This updates a previously published measure summary.
- Medication reconciliation post-discharge: percentage of discharges from January 1 to December 1 of the measurement year for patients 66 years of age and older for whom medications were reconciled on or within 30 days of discharge. This updates a previously published measure summary.
- Potentially harmful drug-disease interactions in the elderly: percentage of Medicare patients 65 years of age and older who have evidence of an underlying disease, condition or health concern and who were dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis. This updates a previously published measure summary.
- Use of high-risk medications in the elderly: percentage of patients 66 years of age and older who received at least one high-risk medication. This updates a previously published measure summary.
- Use of high-risk medications in the elderly: percentage of patients 66 years of age and older who received at least two different high-risk medications. This updates a previously published measure summary.
No hay comentarios:
Publicar un comentario